MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(TSX:BLCO)

23.09 +0.82 (+3.68%)
Streaming Delayed Price Updated: 2:06 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,418
Open 22.94
Bid (Size) 23.02 (1)
Ask (Size) 23.17 (4)
Prev. Close 22.27
Today's Range 22.94 - 23.24
52wk Range 14.56 - 25.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
From Bausch + Lomb Corporation
Via Business Wire

Performance

YTD
+1.3%
+1.3%
1 Month
+2.3%
+2.3%
3 Month
-5.5%
-5.5%
6 Month
+8.7%
+8.7%
1 Year
+37.1%
+37.1%

More News

Read More
News headline image
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Two Board of Directors Appointments
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Participate in Citi Global Healthcare Conference
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Hold Investor Day on Nov. 13
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Third-Quarter 2025 Results
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Board Changes
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Participate in Upcoming Investor Conferences
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Second-Quarter 2025 Results
From Bausch + Lomb Corporation
Via Business Wire

Frequently Asked Questions

Is BLCO publicly traded?
Yes, BLCO is publicly traded.
What exchange does BLCO trade on?
BLCO trades on the Toronto Stock Exchange
What is the ticker symbol for BLCO?
The ticker symbol for BLCO is BLCO on the Toronto Stock Exchange
What is the current price of BLCO?
The current price of BLCO is 23.09
When was BLCO last traded?
The last trade of BLCO was at 04/14/26 02:06 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story